The present invention relates to a new coating system useful for coating particles, which comprise an active ingredient.
Such coated particles, when consumed, do show a controlled release in the human or animal body.
Controlled release is a very important property for particles (such as i.e., tablet, granules etc), in that the active ingredient, which is in the particle, can be delivered to the right place in the human or animal gastrointestinal tract, where the active ingredient is then released.
Such active ingredients can be any commonly used ingredients, such as i.e., a pharmaceutical compound (a drug), a vitamin, a mineral, probiotic, enzyme, eubiotic, plant extract and nutraceutical.
The goal was to find a coating layer that allows the release of the active ingredient inside the particle after passing the stomach in the small intestine.
Surprisingly, it was found that when using a coating system to coat a particle, wherein the coating system is an emulsion consisting of an
Therefore, the present invention relates to a coating system (CS) consisting of an
Therefore, the present invention relates to a coating system (CS1), which is the coating system (CS), wherein the at least one emulsifier is gelatin.
The gelatin can be from any source, such as porcine (pork), bovine (beef or cattle), and fish.
Therefore, the present invention relates to a coating system (CS2), which is the coating system (CS) or (CS1), wherein the at least one plasticizer is chosen from the group consisting of diesters of acids, triesters of acids, diesters of alcohols, triesters of alcohols, polyols and polyethylene glycols.
Therefore, the present invention relates to a coating system (CS2′), which is the coating system (CS) or (CS1), wherein the at least one plasticizer is chosen from the group consisting of triethyl citrate, tributyl citrate, acetyl triethyl citrate and glycerol.
Therefore, the present invention relates to a coating system (CS3), which is the coating system (CS), (CS1), (CS2) or (CS2′), wherein the at least one film forming agent is shellac and/or shellac ammonium salt, polyvinylpyrrolidone (PVP), acrylates, acrylamides, and copolymers thereof.
Therefore, the present invention relates to a coating system (CS4), which is the coating system (CS), (CS1), (CS2), (CS2′) or (CS3), wherein the at least one pH adjuster is chosen from the group consisting of NaOH and KOH.
Therefore, the present invention relates to a coating system (CS5), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3) or (CS4), wherein the at least one enteric coating is a wax.
Therefore, the present invention relates to a coating system (CS5′), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3) or (CS4), wherein the enteric coating is Candelilla wax.
Candelilla wax is a wax derived from the leaves of the small Candelilla shrub native to northern Mexico and the southwestern United States, Euphorbia Cerifera and Euphorbia antisyphilitica, from the family Euphorbiaceae. It is yellowish-brown, hard, brittle, aromatic, and opaque to translucent. Candelilla wax consists of mainly hydrocarbons (about 50%, chains with 29-33 carbons), esters of higher molecular weight (20-29%), free acids (7-9%), and resins (12-14%, mainly triterpenoid esters) Therefore, the present invention relates to a coating system (CS6), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5) or (CS5′), wherein the at least one polyunsaturated fatty acid has 16 to 24 carbon atoms.
Therefore, the present invention relates to a coating system (CS6′), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5) or (CS5′), wherein the at least one polyunsaturated fatty acid is chosen from the group consisting of omega-3 fatty acids, omega-6 fatty acids, omega-9 fatty acids and conjugated fatty acids.
Therefore, the present invention relates to a coating system (CS6″), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5) or (CS5′), wherein the at least one polyunsaturated fatty acid is chosen from the group consisting of oleic acid and linoleic acid.
Therefore, the present invention relates to a coating system (CS7), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′) or (CS6″), wherein the at least one saturated fatty acid has 16 to 24 carbon atoms.
Therefore, the present invention relates to a coating system (CS7′), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′) or (CS6″) wherein the at least one saturated fatty acid is chosen from the group consisting of lauric acid, myristic acid, palmitic acid and stearic acid.
Usually, the emulsion consists of 50-80 weight-% (wt-%), based on the total weight of the emulsion, of the aqueous (water) phase and 20-50 wt-%, based on the total weight of the emulsion, of the oily phase.
Therefore, the present invention relates to a coating system (CS8), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7) or (CS7′), wherein the emulsion consists of 50-80 weight-% (wt-%), based on the total weight of the emulsion, of the aqueous (water) phase and 20-50 wt-%, based on the total weight of the emulsion, of the oily phase.
The aqueous phase of the emulsion comprises
Such auxiliary agents can be i.e. colors, antifoaming agents, flavors, and antioxidants etc.
The aqueous phase of the emulsion consists of
The aqueous phase of the emulsion consists of
Preferably, the aqueous phase of the emulsion comprises
Preferably, the aqueous phase of the emulsion consists of
Preferably, the aqueous phase of the emulsion consists of
Therefore, the present invention relates to a coating system (CS9), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′) or (CS8), wherein the aqueous phase of the emulsion comprises
Therefore, the present invention relates to a coating system (CS9′), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′) or (CS8), wherein the aqueous phase of the emulsion consists of
Therefore, the present invention relates to a coating system (CS9″), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′) or (CS8), wherein the aqueous phase of the emulsion consists of
Therefore, the present invention relates to a coating system (CS9′″), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′) or (CS8), wherein the aqueous phase of the emulsion comprises
Therefore, the present invention relates to a coating system (CS9″ ″), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′) or (CS8), wherein the aqueous phase of the emulsion consists of
Therefore, the present invention relates to a coating system (CS9″″′), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′) or (CS8), wherein the aqueous phase of the emulsion consists of
The oily phase of the emulsion comprises
The oily phase of the emulsion consists of
The oily phase of the emulsion consists of
Preferably, the oily phase of the emulsion comprises
Preferably, the oily phase of the emulsion comprises
Preferably, the oily phase of the emulsion consists of
Preferably, the oily phase of the emulsion consists of
Therefore, the present invention relates to a coating system (CS10), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′), (CS8), (CS9), (CS9′), (CS9″), (CS9′″), (CS9″ ″) or (CS9″″′), wherein the oily phase of the emulsion comprises
Therefore, the present invention relates to a coating system (CS10′), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′), (CS8), (CS9), (CS9′), (CS9″), (CS9′″), (CS9″ ″) or (CS9″″′), wherein the oily phase of the emulsion consists of
Therefore, the present invention relates to a coating system (CS10″), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′), (CS8), (CS9), (CS9′), (CS9″), (CS9′″), (CS9″ ″) or (CS9″″′), wherein the oily phase of the emulsion consists of
Therefore, the present invention relates to a coating system (CS10′″), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′), (CS8), (CS9), (CS9′), (CS9″), (CS9′″), (CS9″ ″) or (CS9″″′), wherein the oily phase of the emulsion comprises
Therefore, the present invention relates to a coating system (CS10″ ″), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′), (CS8), (CS9), (CS9′), (CS9″), (CS9′″), (CS9″ ″) or (CS9″″′), wherein the oily phase of the emulsion comprises
Therefore, the present invention relates to a coating system (CS10″″′), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′), (CS8), (CS9), (CS9′), (CS9″), (CS9′″), (CS9″ ″) or (CS9″″′), wherein the oily phase of the emulsion consists of
Therefore, the present invention relates to a coating system (CS10″″″), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′), (CS8), (CS9), (CS9′), (CS9″), (CS9′″), (CS9″″) or (CS9″″′), wherein the oily phase of the emulsion consists of
All percentages are adding up always to 100% (this applies to all compositions disclosed in this patent application).
Therefore, the present invention relates to a coating system (CS11), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′), (CS8), (CS9), (CS9′), (CS9″), (CS9″ ″), (CS10), (CS10′), (CS10″), (CS10′″) or (CS10″″′), wherein the auxiliary agent is chosen from the group consisting of colors, antifoaming agents, flavors and antioxidants.
As stated above the particles are coated with the coating systems, which are the emulsions described above.
The emulsions used for the coating process should have a viscosity, which is suitable that the emulsion can be sprayed on the particles and that the spraying nozzle is not blocked.
A suitable range of viscosity goes up to 500 mPas. (measured at 45° C. (spraying temperature) using a Brookfield rheometer) Therefore, the present invention relates to a coating system (CS12), which is the coating system (CS), (CS1), (CS2), (CS2′), (CS3), (CS4), (CS5), (CS5′), (CS6), (CS6′), (CS6″), (CS7), (CS7′), (CS8), (CS9), (CS9′), (CS9″), (CS9′″), (CS9″ ″), (CS9″″′), (CS10), (CS10′), (CS10″), (CS10′″), (CS10″″′), (CS10″″′), (CS10″″ ″) or (CS11), wherein the emulsion has a viscosity of up to 500 mPas.
The coating process can be done by using commonly known processes and equipment. Also, the process conditions applied are commonly known and vary depending which process and/or equipment is used.
Typical coating techniques for coating of such tablets are i.e. dip coating, spray coating, film coating fluid bed coating, drum coating and pan coating
It is not essential for the present invention, which process is used.
Preferably, spray coating, drum coating or film coating is used.
Any suitable coating device can be used.
Such equipment is commercially available from a variety of suppliers, such i.e. Glatt (CH), Comasa etc.
The coating process is usually carried out as following
As stated above, the process parameters chosen for the coating are commonly known and used for such a process.
The curing process is usually done by heating the particles up to 90° C. for a period of at least 1 minute. The maximal duration of the curing step is not essential, but it is usually not more than one hour.
Therefore, the curing step is carried for 1 minute to up to one hour.
Preferably the coated particles are undergoing a curing process step.
The coating process is usually carried out as following
When the coating system is applied onto the particle, the water of the emulsion is (more or less) evaporated. This means that the water content of the coating layer of coated particle is less than 5 wt-%, based on the total weight of the coated particles (preferably below 3 wt-%, more preferred below 2 wt-%, even more preferred below 1 wt-%).
The coated particles according to the present invention consists of a core (which is the particle) and the coating layer.
The coated particle according to the present invention consist of
Therefore, the present invention relates to a coated particle (CP) consisting of
As stated above the coating layer is formed by the coating system according to the present invention. Due to the process conditions of the coating process, the water of the coating system is removed (more or less) completely.
Therefore, the present invention relates to a coated particle (CP1) consisting of
Therefore, the present invention relates to a coated particle (CP1′) consisting of
Therefore, the present invention relates to a coated particle (CP1″) consisting of
Preferably, the present invention relates to a coated particle (CP1′″) consisting of
Preferably, the present invention relates to a coated particle (CP1″″′) consisting of
Preferably, therefore, the present invention relates to a coated particle (CP1″″ ″) consisting of
Therefore, the present invention relates to a coated particle (CP2), which is the coated particle (CP1), (CP1′), (CP1′″) or (CP1″″), wherein the auxiliary agent is chosen from the group consisting of colors, antifoaming agents, flavors and antioxidant.
Therefore, the present invention relates to a coated particle (CP3), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″) or (CP2), wherein the at least one emulsifier is gelatine.
The gelatine can be from any source, such as porcine (pork), bovine (beef or cattle), and fish.
Therefore, the present invention relates to a coated particle (CP4), which is coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2) or (CP3), wherein the at least one plasticizer is chosen from the group consisting of diesters of acids, triesters of acids, diesters of alcohols, triesters of alcohols, polyols and polyethylene glycols.
Therefore, the present invention relates to a coated particle (CP4′), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2) or (CP3), wherein the at least one plasticizer is chosen from the group consisting of triethyl citrate, tributyl citrate, acetyl triethyl citrate and glycerol.
Therefore, the present invention relates to a coated particle (CP5), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4) or (CP4′), wherein the at least one film forming agent is shellac and/or shellac ammonium salt, polyvinylpyrrolidone (PVP), acrylates, acrylamides, and copolymers thereof
Therefore, the present invention relates to a coated particle (CP6), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), or (CP5), wherein the at least one pH adjuster is chosen from the group consisting of NaOH and KOH.
Therefore, the present invention relates to a coated particle (CP7), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), (CP5) or (CP6), wherein the at least one enteric coating is a wax.
Therefore, the present invention relates to a coated particle (CP7′), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), (CP5) or (CP6), wherein the enteric coating is Candelilla wax.
Candelilla wax is a wax derived from the leaves of the small Candelilla shrub native to northern Mexico and the southwestern United States, Euphorbia Cerifera and Euphorbia antisyphilitica, from the family Euphorbiaceae. It is yellowish-brown, hard, brittle, aromatic, and opaque to translucent. Candelilla wax consists of mainly hydrocarbons (about 50%, chains with 29-33 carbons), esters of higher molecular weight (20-29%), free acids (7-9%), and resins (12-14%, mainly triterpenoid esters) Therefore, the present invention relates to a coated particle (CP8), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), (CP5), (CP6), (CP7) or (CP7′), wherein the at least one polyunsaturated fatty acid has 16 to 24 carbon atoms.
Therefore, the present invention relates to a coated particle (CP8′), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), (CP5), (CP6), (CP7) or (CP7′), wherein the at least one polyunsaturated fatty acid is chosen from the group consisting of omega-3 fatty acids, omega-6 fatty acids, omega-9 fatty acids and conjugated fatty acids.
Therefore, the present invention relates to a coated particle (CP8″), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), (CP5), (CP6), (CP7) or (CP7′), wherein the at least one polyunsaturated fatty acid is chosen from the group consisting of oleic acid and linoleic acid.
Therefore, the present invention relates to a coated particle (CP9), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), (CP5), (CP6), (CP7), (CP7′), (CP8), (CP8′) or (CP8″), wherein the at least one saturated fatty acid has 16 to 24 carbon atoms.
Therefore, the present invention relates to a coated particle (CP9′), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), (CP5), (CP6), (CP7), (CP7′), (CP8), (CP8′) or (CP8″), wherein the at least one saturated fatty acid is chosen from the group consisting of lauric acid, myristic acid, palmitic acid and stearic acid.
The particles, which are coated by the inventive coating, may have any size and shape, which are meant to be consumed.
As stated above, the shape of the particle (which is the core of the coated particle) does not change substantially when it is coated.
The particles may have a size, which is commonly known for the type of particles. They may be in the form of a monolithic dosage form or multiparticulates (or multiple unit dosage form).
Therefore, the present invention relates to coating particles (CP10), which are the coated particles (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), (CP5), (CP6), (CP7), (CP7′), (CP8), (CP8′), (CP8″), (CP9) or (CP9′), wherein the coated particles are a monolithic dosage form or multiparticulates (or multiple unit dosage form).
The size of the largest dimension relates on the shape of the particle.
The shape can be any known and used, such as spheres, disc-like, bean-like, egg shape etc.
Therefore, a suitable size range goes from below 1 mm to about 1.5 cm (largest dimension).
Therefore, the present invention relates to a coating particle (CP11), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), (CP5), (CP6), (CP7), (CP7′), (CP8), (CP8′), (CP8″), (CP9), (CP9′) or (CP10), wherein the coated particle has a size from below 1 mm to about 1.5 cm (largest dimension).
The particle, which is coated, can be a tablet, capsule, caplet, extrudate, pellet, globuli, granulate, beadlet, etc which comprises at least one active ingredient and optionally at least one further excipient, which are used to produce such a dosage form.
Therefore, the present invention relates to a coating particle (CP12), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), (CP5), (CP6), (CP7), (CP7′), (CP8), (CP8′), (CP8″), (CP9), (CP9′), (CP10) or (CP11), wherein the particle, which is coated, is a tablet, capsule, caplet, extrudate, pellet, globuli, granulate, or a beadlet, which comprises at least one active ingredient and optionally at least one further excipient, which are used to produce such a dosage form.
The particle can also be a pure substance. This means no excipient is used.
The coating layer covers the particle (more or less) equally. This means that the particle is coated completely, and the thickness is more or less the same all over the particle.
The thickness of the coating layer goes from 20 m to 500 m (preferably 50 m to 500 m, more preferably 100 m to 400 m).
The thickness is measured by commonly known methods, such as i.e., scanning electron microscopy.
Therefore, the present invention relates to a coating particle (CP13), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), (CP5), (CP6), (CP7), (CP7′), (CP8), (CP8′), (CP8″), (CP9), (CP9′), (CP10), (CP11) or (CP12), wherein the thickness of the coating is 20 m to 500 μm (preferably 50 m to 500 m, more preferably 100 μm to 400 m).
The active ingredient in the particle can be any suitable one depending on the desired use of the coated particle.
The active ingredient can be a i.e., pharmaceutical compound (a drug), a vitamin, a mineral, probiotic, nutritional lipid, enzyme, eubiotic, plant extract and nutraceutical.
Therefore, the present invention relates to a coating particle (CP14), which is the coated particle (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), (CP5), (CP6), (CP7), (CP7′), (CP8), (CP8′), (CP8″), (CP9), (CP9′), (CP10), (CP11), (CP12) or (CP13), wherein the active ingredient in the particle is chosen from the group consisting of pharmaceutical compound (a drug), a vitamin, a mineral, probiotic, nutritional lipid, enzyme, eubiotic, plant extract and nutraceutical.
When using a vitamin, it can be water and/or fat-soluble vitamin.
Water soluble vitamins are ascorbic acid (vitamin C), thiamin, riboflavin, niacin, vitamin B6 (pyridoxine, pyridoxal, and pyridoxamine), folacin, vitamin B12, biotin, and pantothenic acid.
Fat soluble vitamins are A, vitamin D, vitamin E and vitamin K.
The amount of the at least one active ingredient in the particle can vary depending on the active ingredient and/or on the use of the active ingredient and/or on the dosage regime of the final formulation (which is consumed), etc.
Depending on the active ingredient in the particle (which is the core of the coated particle), the coated particle can be used in various fields of application, such as in a dietary supplement formulation, in a pharmaceutical formulation, in a personal care formulation, in food formulation and feed formulation.
Therefore, the present invention relates to the use of at least one coated particle, which is the coated (CP), (CP1), (CP1′), (CP1″), (CP1′″), (CP1″ ″), (CP1″″′), (CP1″″ ″), (CP2), (CP3), (CP4), (CP4′), (CP5), (CP6), (CP7), (CP7′), (CP8), (CP8′), (CP8″), (CP9), (CP9′), (CP10), (CP11), (CP12), (CP13) or (CP14), in a dietary supplement formulation, in a pharmaceutical formulation, in a personal care formulation, in food formulation and/or feed formulation.
The coated particle according to the present invention can be used as such, or it can be incorporated into a formulation, which can be any commonly known formulation (preferably, it is a dry formulation).
The following examples serve to illustrate specific embodiments of the invention claimed herein. All percentages are given in relation to the weight, and all the temperatures are given in degrees Celsius.
25 g H2O and 4.79 g gelatine and 25 g H2O were firstly introduced in a 800 ml glass beaker. Then, the mixture was left 1 h in a water bath at 35° C.
After 1 h, the gelatine mixture was immersed in a water bath at 68° C. before to add the remaining amount of H2O (150 g) and the glycerol (4.79 g). The mixture was mixed and it was stirred at low speed.
Then, the shellac ammonium salt solution (73.32 g) was added.
Once homogeneous, the pH of the solution was measured and adjusted to 7.89 by addition of 20.77 g of NaOH 30% sol. The solution was placed again the hot bath under stirring.
13.5 g of oleic acid and 6.75 g of stearic acid were firstly introduced in a 250 mL glass beaker. After addition of 135 g of melted wax, the mixture was quickly placed in a water bath at 90° C. under magnetic stirring to mix the different products.
Once the temperature of the aqueous phase reached 65° C., the homogenizer speed (UItraturrax T25) was progressively increased until 24000 rpm while adding the oily phase slowly.
The emulsion was finally sieved using a sieve (mesh size 500 μm).
The coating was performed in a drumcoater Glatt GC 1 equipped with a 0.8 L drum and with the standard 0.8 mm nozzle. A Silicone tubing (2×2×6) from VWR was used to ensure the transportation of the emulsion from the bottle to the nozzle. A water bath allowed to keep the emulsion hot and under stirring during the coating. The drum was filled with 300 g of vitamin B2 Tablets.
The following table shows the composition of the coating system used in Example 1
Release tests realized in a thermoregulated bath (37.5° C.) under stirring (400 RPM) in two different mediums, namely in deionised water and in an acidic buffer solution at pH 3.2
This example was made in accordance to Example 1
The following table shows the composition of the coating system used in Example 2
Release tests realized in a thermoregulated bath (37.5° C.) under stirring (400 RPM) in two different mediums (deionised water and acidic buffer solution):
This example was made in accordance to Example 1
The following table shows the composition of the coating system used in Example 3
Release tests realized in a thermoregulated bath (37.5° C.) under stirring (400 RPM) in two different mediums (deionised water and acidic buffer solution):
It can be seen that the examples of the present invention show a much better release properties than the Comparison Example.
Number | Date | Country | Kind |
---|---|---|---|
21215554.3 | Dec 2021 | EP | regional |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2022/086012 | 12/15/2022 | WO |